Share
There is a 1.2bn market opportunity. Has management or a broker ever said how much of this the company could realistically take? Even 5% would be huge and eqyuate to around 100m nzd revenue. That should put the market cap around the 1bn mark. Im looking to get in but dont fully understand if this is still a spec or with approval of reimbursement its become a more stable business.
it has a significant holding from Harbour asset management. They are in my good books as they backed up a2 milk even during SP dips.
i also like how ANZ offered to take up shares at a premium price. I have never seen that happen before. From a perspective of major shareholders this is looking good. Im thinking if things go well they may even get an asx listing and that will really get the money flowing in.
Does anyone know if they are working on other products? Bladder cancer only seems a bit narrow.
